Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA.
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade.
Titles as indexed on PubMed.